Media Center

Assets intended for use by media professionals.

For general media inquiries only, please call +1 908-740-5633 or e-mail Media Relations. Members of the media seeking information on a specific topic may also contact the following individuals:

Elizabeth Cooney

Title: Enterprise Social Media
Office Phone: +1 267-305-1158
Email: elizabeth.cooney@merck.com

Pamela Eisele

Title: Product, Pipeline & Supply Media Relations
Office Phone: +1 267-305-3558
Email: pamela_eisele@merck.com

Claire Gillespie

Title: Corporate Media Relations
Office Phone: +1 267-305-0932
Email: claire.gillespie@merck.com

 

Additional Contacts

Consumers:

For consumer or patient-related questions, please contact your physician, pharmacist or other health care provider.

To report an adverse experience with a specific Merck product, please call the Merck National Service Center at +1 800-672-6372.

Health Care Professionals:

If you are a physician, pharmacist or other health care provider and have a question(s) or need information about a specific Merck product or service, please call the Merck National Service Center for Health Care Professionals at +1 866-448-7590.

For Stock Holders:

Tel: +1 800-522-9114
Monday-Friday, 7AM – 7 PM CST

For Institutional Investors and Analysts:

Tel: +1 908-423-5881
Monday-Friday, 8:30 AM – 4 PM ET

Merck Corporate

Photography

Keytruda

Kenneth C. Frazier

ISENTRESS HD

DELSTRIGO

PIFELTRO

Company Snapshot

From developing new therapies that treat and prevent disease to helping people in need, we're committed to improving health and well-being around the world. Visit our About Us section.

 
COMPANY FACT SHEET

Everything you need to know about Merck.

PIPELINE

Our pipeline is continually evolving and is updated quarterly.

OUR LEADERSHIP

How we govern ourselves as a company is as important as anything else we do.

Join the Conversation

Connect with us on Facebook, Twitter, and LinkedIn to learn more about our corporate initiatives, including those in health and wellness, philanthropy and corporate responsibility.

Scott M. Wright, Social Media +1 267-305-3581 Scott.Wright@merck.com

Please read our social media guidelines.

There are 3 major consequences associated with #CMV infection #TCTM19 #HSCT https://t.co/nQL3DN4UHW-1 min 47 sec ago
More than 30% of patients who are #CMV seropositive reactivate within 30 days of stem cell transplant #TCTM19 #HSCT https://t.co/SdHySHX3aK-19 hours 31 min ago
#DYK the risk factors for #CMV reactivation and infection? #TCTM19 #HSCT https://t.co/Xk0tIEhDK0-23 hours 1 min ago
#TCTM2019 Poll Results: The answer is D. All of the above!-1 day 16 hours ago
CEO Ken Frazier on former American Express CEO Ken Chenault on the PBS tribute An Evening With Ken Chenault.… https://t.co/9c27HPhI9P-1 day 18 hours ago
Merck
Though many advances in HIV research have been made since the start of the epidemic in the 1980s, more work is to be done. Learn about our work: b​i​t​.​l​y​/​2​m​y​K​H​m​v
about 3 days 22 hours ago
Merck
Learn more about our work in kidney cancer: b​i​t​.​l​y​/​2​I​b​s​y​G​b #GU19
ASCO_KidneyCancer_Most Common_MCK_1920x1080.mp4
about 6 days 19 hours ago
Merck
Despite new discoveries in #bladdercancer research, there is still a need for scientific advancement. Watch as our team shares what drives them to address this need. b​i​t​.​l​y​/​2​t​n​1​8​m​m #InventingForLife #GU19
ASCO_Bladder Cancer_2019 Diagnosis_MCK_1920x1080.mp4
about 1 week ago